Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Sight Sciences (SGHT)
TipRanksApr 10 05:40 ET
Sight Sciences Analyst Ratings
BenzingaApr 10 05:23 ET
Sight Sciences Analyst Ratings
BenzingaMar 8 10:46 ET
Sight Sciences (SGHT) Receives a Hold From Piper Sandler
TipRanksMar 8 07:47 ET
Analysts Conflicted on These Healthcare Names: RAPT Therapeutics (RAPT), Eli Lilly & Co (LLY) and Sight Sciences (SGHT)
TipRanksMar 8 05:41 ET
Needham Remains a Hold on Sight Sciences (SGHT)
TipRanksMar 8 05:40 ET
Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Integer Holdings (ITGR) and Pacific Biosciences (PACB)
TipRanksFeb 16 07:30 ET
Needham Remains a Hold on Sight Sciences (SGHT)
TipRanksJan 9 06:05 ET
Needham Remains a Hold on Sight Sciences (SGHT)
TipRanksDec 28, 2023 12:35 ET
Morgan Stanley Maintains Equal-Weight on Sight Sciences, Raises Price Target to $4
BenzingaDec 4, 2023 07:47 ET
Sight Sciences Analyst Ratings
BenzingaDec 4, 2023 07:46 ET
Reevaluation of Sight Sciences' Financial Performance Amid Q3 Results and Reimbursement Uncertainty: A Hold Rating and Lowered Price Target
TipRanksNov 13, 2023 19:48 ET
Stifel Nicolaus Remains a Buy on Sight Sciences (SGHT)
TipRanksNov 12, 2023 21:05 ET
Sight Sciences Analyst Ratings
BenzingaNov 8, 2023 16:34 ET
Piper Sandler Sticks to Their Hold Rating for Sight Sciences (SGHT)
TipRanksOct 13, 2023 06:36 ET
Piper Sandler Reaffirms Their Hold Rating on Sight Sciences (SGHT)
TipRanksSep 25, 2023 06:55 ET
Sight Sciences Analyst Ratings
BenzingaSep 18, 2023 10:48 ET
Citigroup Maintains Neutral on Sight Sciences, Lowers Price Target to $4
BenzingaSep 15, 2023 10:09 ET
Sight Sciences Analyst Ratings
BenzingaSep 15, 2023 10:09 ET
Morgan Stanley Maintains Equal-Weight on Sight Sciences, Lowers Price Target to $4
BenzingaSep 13, 2023 09:01 ET
No Data
No Data